Search

everythinglearnresearchcommunity

for

Search:↓

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

Ritlecitinib is more effective and cost-efficient than baricitinib for severe alopecia areata.

A rare tumor caused unusual hormone production leading to Cushing syndrome.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Stereotactic body radiation therapy and radiosurgery are advanced, precise treatments that target tumors while protecting healthy tissue.

The right amount of retinoic acid is essential for normal hair growth and development.

PTH-CBD could help prevent and treat hair loss caused by chemotherapy in mice.

Corticosteroids improved symptoms in a man with Cronkhite-Canada Syndrome.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

Early detection of ovarian steroid cell tumors is crucial to prevent lasting symptoms.

A girl had rickets due to a gene mutation affecting vitamin D response.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

Adults with Tatton-Brown-Rahman syndrome may have serious heart problems and need lifelong heart monitoring.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Glucocorticoid treatment lowered androgen levels but didn't improve hirsutism or ovulation and caused weight gain.

Hormone therapy can improve sexual health and quality of life for women 70 and older.

A hair test shows promise for early mood disorder diagnosis.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

The method can measure multiple hormones in women's hair and may help identify hormone-related health issues.

Allergens might contribute to CCCA, so avoiding them could help manage the condition.

CE-PTG detects early hair follicle issues in balding areas, helping measure male hair loss.

A woman with both Cronkhite-Canada syndrome and myelodysplastic syndrome improved significantly with corticosteroid treatment.

A young patient with unusual insulin resistance and high testosterone levels had a rare INSR gene mutation.

Hair loss and excessive growth treated with various options, including new laser technology.

New treatments for hair loss, including a compound called "ALRV5XR", platelet-rich plasma, and Adult Stem Cell-based therapy, are showing promise, but more trials are needed for confirmation.

Most patients with Central Centrifugal Cicatricial Alopecia at the reviewed institution were middle-aged Black women, often with no symptoms, and commonly treated with topical medications.

A patient with Cronkhite-Canada syndrome improved with nutritional support and steroids, but early diagnosis is key due to high mortality.

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.